𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Valvular heart disease in patients with Parkinson’s disease treated with pergolide. Course following treatment modifications

✍ Scribed by D. Dupuy; J. P. Lesbre; P. Gérard; M. Andrejak; O. Godefroy

Publisher
Springer
Year
2008
Tongue
English
Weight
168 KB
Volume
255
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
✍ Ji-Youn Kim; Eun Joo Chung; Seung Woo Park; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Valvular heart disease, associated with ergot derivative dopamine agonists, has been reported in patients with Parkinson's disease (PD). There are few comparative studies on the frequency, severity, and dose dependency of valvular disease associated with ergot derivatives. We analyzed these factors

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study
✍ Susann Junghanns; Joerg T. Fuhrmann; Gregor Simonis; Christian Oelwein; Rainer K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract Fibrotic valvular heart disease (VHD) has been reported in association with ergot dopamine agonists (DAs), but the current database is insufficient regarding clinical relevance and comparison to data on non‐ergot DAs. We evaluated the effects of four DAs (pergolide, cabergoline, ropinir